These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16163220)

  • 1. The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement?
    Josephson CD; Abshire T
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):441-6. PubMed ID: 16163220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of recombinant factor VIII products in patients with hemophilia A.
    Musso R
    Drugs Today (Barc); 2008 Oct; 44(10):735-50. PubMed ID: 19137127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience.
    Afonja O; Kozak R; Petraro P; Michaels LA; Mathew P; Lemm G; Kessler C
    Expert Rev Hematol; 2016 Dec; 9(12):1151-1164. PubMed ID: 27841041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and epidemiological modelling of full-length antihaemophilic factor (recombinant), plasma/albumin-free method, in previously treated patients with haemophilia A : comparison with B-domain deleted rFVIII, and value of potential viral transmission reduction due to plasma/albumin-free status.
    Sclar DA; Evans MA; Skaer TL; Robison LM; Chung KC; Poulios NS
    Drugs R D; 2005; 6(3):149-56. PubMed ID: 15869318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely?
    Suiter TM
    Semin Thromb Hemost; 2002 Jun; 28(3):277-84. PubMed ID: 12098089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production processes of licensed recombinant factor VIII preparations.
    Boedeker BG
    Semin Thromb Hemost; 2001 Aug; 27(4):385-94. PubMed ID: 11547361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIII concentrates.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2010 Jul; 36(5):493-7. PubMed ID: 20632247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
    Zollner SB; Raquet E; Müller-Cohrs J; Metzner HJ; Weimer T; Pragst I; Dickneite G; Schulte S
    Thromb Res; 2013 Aug; 132(2):280-7. PubMed ID: 23830969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of recombinant factor VIII products in previously treated patients with hemophilia A: pharmacokinetics, efficacy, safety, and inhibitor development.
    Lee C
    Semin Thromb Hemost; 2002 Jun; 28(3):241-6. PubMed ID: 12098083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should hemophilia treaters switch to albumin-free recombinant factor VIII concentrates.
    Meeks SL; Josephson CD
    Curr Opin Hematol; 2006 Nov; 13(6):457-61. PubMed ID: 17053459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review.
    Hassan S; Cannavò A; Gouw SC; Rosendaal FR; van der Bom JG
    J Thromb Haemost; 2018 Jun; 16(6):1055-1068. PubMed ID: 29665204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluation.
    D'Amici GM; Timperio AM; Gevi F; Grazzini G; Zolla L
    Electrophoresis; 2010 Aug; 31(16):2730-9. PubMed ID: 20737444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How we choose factor VIII to treat hemophilia.
    Mannucci PM; Mancuso ME; Santagostino E
    Blood; 2012 May; 119(18):4108-14. PubMed ID: 22411872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors.
    Delignat S; Peyron I; El Ghazaly M; V Kaveri S; Rohde J; Mueller F; Lacroix-Desmazes S
    Cell Immunol; 2018 Sep; 331():22-29. PubMed ID: 29751951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.
    Lusher JM
    Semin Thromb Hemost; 2002 Jun; 28(3):273-6. PubMed ID: 12098088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII--Baxter: rAHF-PFM, recombinant anti-haemophilic factor--protein-free method, recombinant factor VIII--protein-free.
    Drugs R D; 2003; 4(6):366-8. PubMed ID: 14584967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits.
    Schiavoni M; Napolitano M; Giuffrida G; Coluccia A; Siragusa S; Calafiore V; Lassandro G; Giordano P
    Front Med (Lausanne); 2019; 6():261. PubMed ID: 31850352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIII.
    Singleton E; Smith J; Kavanagh M; Nolan B; White B
    Thromb Haemost; 2007 Dec; 98(6):1188-92. PubMed ID: 18064312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group.
    Abshire TC; Brackmann HH; Scharrer I; Hoots K; Gazengel C; Powell JS; Gorina E; Kellermann E; Vosburgh E
    Thromb Haemost; 2000 Jun; 83(6):811-6. PubMed ID: 10896230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison.
    Hay CRM; Palmer BP; Chalmers EA; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Collins PW
    Haemophilia; 2015 Mar; 21(2):219-226. PubMed ID: 25382829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.